NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Encodia

Private
San Diego, CaliforniaHealthcare & Life Sciences

Last Round

Grant

May 1, 2021

Total Funding Raised

$75.7M

Company Overview

Encodia is a biotechnology company that develops a next-generation digital proteomics platform utilizing single-molecule protein sequencing for scalable protein analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

protein sequencingproteomicsnext-generation sequencingNGSbiotech instrumentationproteomics platformdrug discoverybiomarker identificationDNA-barcoded proteomicsreverse-translationbenchtop sequencersingle-molecule sequencinglife sciences toolsmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Encodia Comparables

Compare Encodia with similar companies based on industry and business-model similarity.

Encodia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Glyphic Biotechnologies
87%
Erisyon
84%
Prisma Biotechnology
82%

Encodia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2021
Series CJan 27, 2021
GrantSep 13, 2018
GrantSep 1, 2017
GrantSep 1, 2016

Encodia Investors

Notable investors and investment history

Encodia investors
InvestorRounds
Deerfield ManagementSeries C
National Cancer InstituteGrant
GVSeries C
NIH RADxGrant
ARCH Venture PartnersSeries C, Series B, Series A
Nan Fung Life SciencesSeries C
Northpond VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 75% MoM.

  • May 1, 2021

    $256K grant received from National Institute of General Medical Sciences.

Encodia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Encodia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Encodia's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range18
Year Founded2015
Last FundingMay 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.